CDEK
← All drugs Report issue

Pegfilgrastim

Recombinant proteinexperimental

Clinical trial activity

16 trials · 33 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
8
Phase 3
1
Phase 4
1

Earliest trial started Sep 1, 2002 (NCT00282412)

Timeline

2000s

  1. Jan 1, 2002

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2012

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2013

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Also known as

  • b12019
  • empegfilrastim
  • hsa-gcsf
  • pegteograstim

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07018271N/AJun 30, 2025Soochow University
NCT06690775Phase 2Nov 20, 2024European Network for Gynaecological Oncological Trial, University of California, Los Angeles
NCT06698861Phase 1Aug 19, 2024Novotech, PharmaEssentia Corp.
NCT06168188Early Phase 1 (Phase 1)Jul 24, 2020Tzu Chi University
NCT04066179N/AAug 20, 2019Institute of Liver and Biliary Sciences, India
NCT03547830Phase 2May 29, 2018Federal Research Institute of Pediatric Hematology, Oncology and Immunology
NCT03703674Phase 4Nov 19, 2017Postgraduate Institute of Medical Education and Research
NCT03251768Phase 2Oct 22, 2017Chinese Academy of Medical Sciences, Fortune Rock
NCT02787876Phase 2Oct 4, 2016Green Cross Corporation, Sungkyunkwan University
NCT02840539Phase 2Oct 1, 2016Consortium for Improving Survival of Lymphoma, Seoul National University
NCT03246009Phase 1Jan 21, 2016Chinese Academy of Medical Sciences, Fortune Rock
NCT02629562Phase 1Nov 1, 2015Cinfa Biotech, Nuvisan Pharma Services
NCT02465801Phase 2Dec 1, 2014Fortune Rock
NCT02104830Phase 3Sep 1, 2013Bangalore Institute of Oncology, Biocad, Donetsk City Municipal Oncology Dispensary, Donetsk Regional oncology centers, Government of Russia, Government of Tatarstan, Kharkiv Regional Clinical Oncology Center, Mordovia State University, M.S. Ramaiah Medical College, Bangalore, India, Narayana Hrudayalaya Limited, Non-State Healtcare Institution Road Clinical Hospital of Open Joint Stock Company Russian Railways, Russian Academy of Medical Sciences, Russian Military, Vinnitskii Regional Oncology Dispensary, Zakarpatskii Regional Clinical Oncology Dispensary
NCT01569087Phase 2May 1, 2012Biocad
NCT00282412Phase 1Sep 1, 2002Northwestern University
Showing 16 of 16 trials
Page 1 / 1

Organizations

Research & Development (33)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Fortune RockFor profit3322014
BiocadFor profit2222012
Chinese Academy of Medical SciencesAcademic/Hospital2022016
Bangalore Institute of OncologyAcademic/Hospital1012013
Cinfa BiotechFor profit1112015
Consortium for Improving Survival of LymphomaAcademic/Hospital1012016
Donetsk City Municipal Oncology DispensaryAcademic/Hospital1012013
Donetsk Regional oncology centersAcademic/Hospital1012013
European Network for Gynaecological Oncological TrialAcademic/Hospital1012024
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyGovernment1112018
Government of RussiaGovernment1012013
Government of TatarstanGovernment1012013
Green Cross CorporationFor profit1012016
Institute of Liver and Biliary Sciences, IndiaAcademic/Hospital1112019
Kharkiv Regional Clinical Oncology CenterAcademic/Hospital1012013
Mordovia State UniversityAcademic/Hospital1012013
M.S. Ramaiah Medical College, Bangalore, IndiaAcademic/Hospital1012013
Narayana Hrudayalaya LimitedAcademic/Hospital1012013
Non-State Healtcare Institution Road Clinical Hospital of Open Joint Stock Company Russian RailwaysAcademic/Hospital1012013
Northwestern UniversityAcademic/Hospital1112002
33 organizations
Page 1 / 2